An interventional study of Intensive intervention for smoking cessation and Brief intervention for smoking cessation in Smoking, Smoking Cessation and Surgical Procedure, Unspecified, sponsored by Hospital Universitari Vall d'Hebron Research Institute. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-27.
Sponsored by Hospital Universitari Vall d'Hebron Research Institute · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Smoking with a site in Spain — 4 open to participants now, 5 under way, none of them phase 3. Smoking · Spain.
Among the 27 studies in Smoking with a site in Spain, this one is the 16th largest by planned enrollment of the 19 interventional ones that give a count, is one of 3 that started in 2023, is one of 15 with no phase, and was the 24th registered.
1,516 studies on the registry are indexed under Smoking; 196 are open to participants now.
Browse Smoking studies →4 of the 27 studies in Smoking with a site in Spain are open now. Recruiting first, the newest first:
University of Santiago de Compostela · Sites in Spain
Ages 18+ · Healthy volunteers
Institut Català d'Oncologia · Sites in Spain
Ages 18+ · Healthy volunteers
Susana Al-Halabí · Sites in Spain
Ages 12–15 · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 145 Smoking studies recruiting now, 76 (52%) set no upper age limit and 51 (35%) stop at 75 or younger; 3 take children under 18; 69 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2023.
This study's planned enrollment of 232 is above the median of 116 across 1,167 interventional studies indexed under Smoking.
Median enrollment 408 across the 19 interventional studies, 1,260 across the 8 observational. Of the 16 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 27 have an industry lead sponsor. The 10 most frequent:
Hospital Universitari Vall d'Hebron Research Institute is the lead sponsor of 276 studies on the registry; 63 are open to participants now.
Hospital Universitari Vall d'Hebron Research Institute has 2 studies filed under Smoking — fewer than ten, so there is no comparison to draw.
1 of the studies in Smoking with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06932276Institut Català d'OncologiaImplementing an Adapted Smoke-free Homes Intervention in Spain | 2027-01-30 |
Add it to your calendar (.ics) → With an account.
Among the 27 studies in Smoking with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to assess efficacy of an intensive pre-surgical intervention to quit smoking in smoking patients who will be operated on implant orthopedic surgery or general and urological surgery. The main question[s] it aims to answer are:
Participants will be randomized to 2 intervention groups (patients programmed for protesic implant orthopedic surgery in the first group, and general and urological surgery) and 2 control groups (stratified in the same manner as the intervention groups), and will be monitored through telematic check ups via phone calls.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will be sent to a specialized preventive medicine consult to quit smoking.
Behavioral: Intensive intervention for smoking cessation
58 patients programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will be sent to a specialized preventive medicine consult to quit smoking.
Behavioral: Intensive intervention for smoking cessation
58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will receive a brief intervention for smoking cessation.
Behavioral: Brief intervention for smoking cessation
58 programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will receive a brief intervention for smoking cessation.
Behavioral: Brief intervention for smoking cessation
Patients will be given a brochure and presentation on smoking cessation and will complete 6 visits (2 before surgical intervention, 4 visits within the following 12 months), as well as follow up phone calls for progressi monitorization.
Patients will be given a brochure and presentation on smoking cessation 4 weeks before surgery, as well as follow up phone calls for progressi monitorization.
Tobacco use
Change in self reported tobacco use (smoking)
Time frame: Evaluated at 1, 3, 6, and 12 months after surgical intervention
Changes in concentration of exhaled CO measured with a CO-oximeter
A patient will be considered as an active tobacco user if more than 6 of carboxyhemoglobin particles per million are found through the use of a CO-oximeter
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Changes in rate of different type of tobbaco product users
Cigarettes, cigars, rolling tobacco, etc.
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Changes in tobacco use pattern
Amount and frequency (daily, weekly, sporadically)
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Changes in degree of nicotine dependency
Fagerström test \[low dependency (0-3), medium dependency (4-6), y high dependency (7-10)\]
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Changes in disposition to smoking cessation
Prochaska and Di Clemente's model (pre contemplation, contemplation, preparation, action, maintenance or relapse)
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Changes in Motivation level
Richmond's test (\<3 no motivation; 4-5 doubtful motivation; 6-7 moderate motivation; 8-10 high motivation)
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Changes in self-efficacy
Albert Bandura's social cognitive theory
Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention
Number of patients with surgical complicatoins
Complications will be classified as respiratory, cardiovascular, surgical wound and complications, mortality
Time frame: Hospitalization period and 90 days after surgical intervention.
Surgery duration
Time spent in the operation room
Time frame: Day of intervention
Need of blood transfusion
Volume of blood transfused during surgery
Time frame: Day of intervention
Hospitalization duration
Number of days of hospitalization after surgery.
Time frame: Days from admitting until discharge.
Need of new hospitalizations
Number of times patient is admitted to the hospital during follow up
Time frame: 12 months after surgical intervention.
Plan to share: No
No publications or documents are linked to this record.
Started May 2023 (actual). Primary completion is estimated for Jun 2025, 24 months after the start.
Of 405 non-industry interventional studies with no phase under Smoking, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 24 months is close to that.
Counting every sponsor, half of 461 studies reached it within 23 months; a quarter within 8 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Universitari Vall d'Hebron Research Institute →